BHC - Company ID 0000885590
The table below shows Bausch Health Companies Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $10.27B | $9.63B | $8.76B | $8.12B | $8.43B | $8.03B |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $3.44B |
Bausch Health Companies Inc. reported annual revenue of $10.27B for fiscal year 2025. That is up 6.7% from $9.63B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $9.67B (FY 2016) to $10.27B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $3.30B |
| $2.92B |
| $2.63B |
| $2.62B |
| $2.37B |
| Operating income | $1.81B | $1.55B | $963.00M | $454.00M | $450.00M | $676.00M |
| Income tax | $247.00M | $239.00M | $221.00M | $83.00M | -$87.00M | -$375.00M |
| Net income | $157.00M | -$46.00M | -$592.00M | -$225.00M | -$948.00M | -$560.00M |
| EPS (diluted) | $0.42 | -$0.13 | -$1.62 | -$0.62 | -$2.64 | -$1.58 |